Asthma in the era of COVID-19

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F23%3A10001182" target="_blank" >RIV/00064190:_____/23:10001182 - isvavai.cz</a>

Alternative codes found

RIV/00216208:11110/23:10469995

Result on the web

<a href="https://www.resmedjournal.com/action/showPdf?pii=S0954-6111%2823%2900261-5" target="_blank" >https://www.resmedjournal.com/action/showPdf?pii=S0954-6111%2823%2900261-5</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.rmed.2023.107373" target="_blank" >10.1016/j.rmed.2023.107373</a>

Result language

angličtina

Original language name

Asthma in the era of COVID-19

Original language description

Since its global invasion in 2019, COVID-19 has affected several aspects of patients&apos; lives and posed a significant impact on the health care system. Several patient populations were identified to be at high risk of contracting SARS-CoV-2 infection and/or developing severe COVID-19-related sequelae. Conversely, anyone who has contracted SARS-CoV-2 is at risk to experience symptoms and signs consistent with post-COVID manifestations. Patients with asthma were initially thought to be at increased risk and severity for SARS-CoV-2 infection. However, accumulating evidence demonstrates that asthma endotypes/phenotypes and comorbidities influence the risk stratification in this population. Furthermore, initial concerns about the potentially increased risk of poor outcomes with asthma treatments such as inhaled corticosteroids and biologics have not been substantiated. In this review, we provide an update on COVID-19 and asthma, including risk of susceptibility, clinical manifestations and course in this population as well as discuss recommendations for management. (C) 2023

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30203 - Respiratory systems

Project

—

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2023

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

RESPIRATORY MEDICINE

ISSN

0954-6111

e-ISSN

1532-3064

Volume of the periodical

218

Issue of the periodical within the volume

11/2023

Country of publishing house

GB - UNITED KINGDOM

Number of pages

8

Pages from-to

—

UT code for WoS article

001076741000001

EID of the result in the Scopus database

2-s2.0-85170097023